U.S. FDA Approves Akebia’s Vadadustat For CKD-induced Anemia

U.S. FDA Approves Akebia’s Vadadustat For CKD-induced Anemia

On March 27, the U.S. Food and Drug Administration (FDA) granted approval to Akebia Therapeutics’ (AKBA.O) drug, vadadustat, for the…